SCHEMBL5460799

SCHEMBL5460799

CCNC(=O)N(Cc1cccc(N(C)C)c1)Cc1cc2cc(C)cc(C)c2[nH]c1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.55
NPSR1 Q6W5P4 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
GUSB P08236 5/20 0.51
KDM4E B2RXH2 5/20 0.51
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
HSD17B10 Q99714 2/20 0.50
NPY1R P25929 1/20 0.50
NPY2R P49146 1/20 0.50
MAPT P10636 3/20 0.49
POLB P06746 1/20 0.49
THRB P10828 1/20 0.49
HTT P42858 1/20 0.48
LMNA P02545 2/20 0.47
USP2 O75604 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4081588 0.89 ALDH1A1 (0.65) ALDH1A1NPSR1SMN1; SMN2GUSBKDM4E
SCHEMBL4069789 0.88 ALDH1A1 (0.53) ALDH1A1NPSR1SMN1; SMN2GUSBKDM4E
SCHEMBL4073221 0.84 POLB (0.69) ALDH1A1NPSR1SMN1; SMN2GUSBKDM4E
SCHEMBL5454251 0.83 MAPT (0.54) ALDH1A1NPSR1SMN1; SMN2GUSBKDM4E
SCHEMBL4081580 0.82 ALDH1A1 (0.55) ALDH1A1NPSR1SMN1; SMN2GUSBKDM4E
SCHEMBL4074569 0.81 GUSB (0.60) ALDH1A1NPSR1SMN1; SMN2GUSBKDM4E
SCHEMBL4072964 0.76 GUSB (0.59) ALDH1A1NPSR1GUSBKDM4EMEN1
SCHEMBL4077438 0.75 KDM4E (0.54) ALDH1A1NPSR1SMN1; SMN2GUSBKDM4E
SCHEMBL4073864 0.74 KDM4E (0.55) ALDH1A1NPSR1SMN1; SMN2GUSBKDM4E
SCHEMBL4077914 0.74 ALDH1A1 (0.55) ALDH1A1NPSR1SMN1; SMN2KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof AGRIUS GROUP, LLC. 2007-12-13 US claimed
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof AGRIUS GROUP, LLC. 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287706-A1 Certain substituted quinolones, compositions, and uses thereof ABCG2, ATP5ME, ATP5MG ALDH1A1 1055/4885NPSR1 4425/4885SMN1; SMN2 4654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.